Maternal and infant predictors of early mother-to-child transmission among HIV-exposed infants in the Karamoja region, Northeastern Uganda 2020–2023, a retrospective cross-sectional study

Read full text Summarise with VIRAT
Authors: Saadick Mugerwa Ssentongo, Susan Alwedo, Bonniface Oryokot, Ronald Opito, Lameck Lumu Bukenya, Simon Peter Ijala, Robin Chepukurui, Peter Sekiranda, Timothy Otaala, Rogers Kyagulanyi, Yunus Miya, Baker Bakashaba
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Despite Uganda making significant progress in reducing mother-to-child transmission (eMTCT), from 20% in 2000 to 2.8% in 2021, regional differences in MTCT rates exist. The drivers of these differences remain unclear in some nomadic populations of the Karamoja region. This study aimed to determine the maternal and infant predictors of HIV infection among HIV-exposed infants (HEI) under 18 months of age in the Karamoja region, Northeastern Uganda. METHODS: We conducted a retrospective cross-sectional study across twelve public health facilities in Karamoja, Uganda. Data on mothers and their HEI who had their first HIV nucleic acid amplification test at 4 to 6 weeks of age by either dry blood test or point of care testing were abstracted from the Early Infant Diagnosis (EID) register. The primary outcome was an HEI PCR test result (Positive or Negative). Firth’s penalized likelihood regression was used to determine factors associated with Infant HIV positivity. Data was analyzed using STATA version 15, and a p-value of < 0.05 was considered significant. RESULTS: A total of 223 mother-baby pairs were included in the analysis, with 52.9% (n=118) of the HEI being female, and the maternal median age was 27 (interquartile range 23-30). The Infant HIV positivity was 2.2% (n=5) and was significantly lower among mothers with no advanced HIV disease (stage 1 or 2)[adjusted odds ratio (aOR): 0.008, 95% confidence interval (CI): 0.0002- 0.35 P=0.012], Mothers having a suppressed viral load (

Fields of Study & Subjects

HIV/AIDS Research and Interventions Global Maternal and Child Health HIV/AIDS drug development and treatment

Publication details

Journal / source
BMC Infectious Diseases
Volume
26
Issue
1
Publication date
28 March 2026
Language
EN